We are live on
!
Find out more
PVWM
Point View Wealth Management Portfolio holdings
AUM
$246M
Turnover
8.93%
1-Year Est. Return
10.77%
This Fund
S&P 500
This Quarter
Est. Return
+18.12%
1 Year Est. Return
+10.77%
3 Year Est. Return
+27.03%
5 Year Est. Return
+74.48%
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$25.9M
(+14%)
Cap. Flow
-$3.29M
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
17.76%
Holding
270
New
17
Increased
39
Reduced
156
Closed
12
Avg Time Held
4.1
years
Top 10 Avg Time Held
2.7
years
Top 20 Avg Time Held
3.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$422K |
| 2 |
Ventas
VTR
|
+$339K |
| 3 |
Comcast
CMCSA
|
+$309K |
| 4 |
Marriott International
MAR
|
+$301K |
| 5 |
AbbVie
ABBV
|
+$285K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$769K |
| 2 |
BP
BP
|
+$302K |
| 3 |
SLB Ltd
SLB
|
+$289K |
| 4 |
Carnival PLC
CUK
|
+$289K |
| 5 |
RTN
Raytheon Company
RTN
|
+$252K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.97% |
| 2 | Miscellaneous | 13.39% |
| 3 | Healthcare | 12.96% |
| 4 | Industrials | 9.62% |
| 5 | Financials | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Eastman Chemical
EMN
$7.13B
| $1.25M | 0.6% |
17,949
-153
| -0.8% | -$9.64K |
2015 Q1
21 quarters
|
|
52
Gilead Sciences
GILD
$194B
| $1.17M | 0.56% |
15,186
-1,545
| -9% | -$118K |
2016 Q1
17 quarters
|
|
53
Emerson Electric
EMR
$90.1B
| $1.13M | 0.54% |
18,181
-549
| -3% | -$31.2K |
2015 Q4
18 quarters
|
|
54
Johnson & Johnson
JNJ
$616B
| $1.12M | 0.54% |
7,968
-222
| -3% | -$32.4K |
2013 Q4
26 quarters
|
|
|
55
AbbVie
ABBV
$504B
| $1.11M | 0.53% |
11,313
+3,237
| +40% | +$285K |
2016 Q4
14 quarters
|
|
56
America Movil
AMX
$68.4B
| $1.11M | 0.53% |
87,272
+299
| +0.3% | +$3.73K |
2013 Q4
26 quarters
|
|
57
DELISTED
Walgreens Boots Alliance
WBA
| $1.1M | 0.53% |
26,066
-413
| -2% | -$17.5K |
2019 Q2
4 quarters
|
|
58
Capital One
COF
$124B
| $1.06M | 0.51% |
16,875
-1,551
| -8% | -$96.6K |
2016 Q4
14 quarters
|
|
59
Altria Group
MO
$125B
| $1.05M | 0.51% |
26,843
-1,190
| -4% | -$46.4K |
2013 Q4
26 quarters
|
|
60
Vodafone
VOD
$37.3B
| $1.04M | 0.5% |
65,246
-642
| -1% | -$9.69K |
2013 Q4
26 quarters
|
|
61
United Rentals
URI
$64.1B
| $1.03M | 0.5% |
6,928
-562
| -8% | -$71.3K |
2018 Q4
6 quarters
|
|
62
Allspring Multi-Sector Income Fund
ERC
$238M
| $1.02M | 0.49% |
92,664
-964
| -1% | -$9.91K |
2014 Q3
23 quarters
|
|
63
Apple
AAPL
$5.01T
| $1M | 0.48% |
10,984
-224
| -2% | -$17.4K |
2016 Q4
14 quarters
|
|
|
RDS.A
64
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1M | 0.48% |
30,593
+3,740
| +14% | +$128K |
2013 Q4
26 quarters
|
|
65
Williams-Sonoma
WSM
$29.5B
| $998K | 0.48% |
24,338
-1,398
| -5% | -$47.6K |
2016 Q3
15 quarters
|
|
|
BF
66
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
| $992K | 0.48% |
70,805
-466
| -0.7% | -$6.53K |
2018 Q4
6 quarters
|
|
67
AstraZeneca
AZN
$257B
| $991K | 0.48% |
9,371
-96
| -1% | -$9.91K |
2013 Q4
26 quarters
|
|
68
Eaton
ETN
$152B
| $983K | 0.47% |
11,237
-1,696
| -13% | -$140K |
2015 Q2
20 quarters
|
|
|
SAFM
69
DELISTED
Sanderson Farms Inc
SAFM
| $968K | 0.46% |
8,351
| – | – |
2015 Q3
19 quarters
|
|
70
CoreCivic
CXW
$3.03B
| $937K | 0.45% |
100,064
-7,404
| -7% | -$84.4K |
2016 Q3
15 quarters
|
|
71
Cigna
CI
$79.9B
| $920K | 0.44% |
4,904
-309
| -6% | -$58.6K |
2013 Q4
26 quarters
|
|
|
NTT
72
DELISTED
Nippon Telegraph & Telephone
NTT
| $916K | 0.44% |
39,285
-1,304
| -3% | -$30.4K |
2013 Q4
26 quarters
|
|
|
IGR
73
CBRE Global Real Estate Income Fund
IGR
$564M
| $910K | 0.44% |
50,803
-719
| -1% | -$12.3K |
2017 Q2
12 quarters
|
|
74
Best Buy
BBY
$19.4B
| $895K | 0.43% |
10,261
-123
| -1% | -$9.33K |
2013 Q4
26 quarters
|
|
75
Newmont
NEM
$125B
| $893K | 0.43% |
14,460
-734
| -5% | -$43.4K |
2016 Q1
17 quarters
|
|
Similar funds
EA
CCM
JCM
BG
MCFIG
BRC
TFM
RCA
Point View Wealth Management's Q2 2020 Portfolio in Review
As of Q2 2020, Point View Wealth Management held 270 positions worth $208M, up 14% from $183M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Point View Wealth Management's Q2 2020 filing shows 17 new, 39 increased, 156 reduced and 12 closed positions. Its largest new stake was Lowe's Companies: 3,692 shares worth $499K. The largest sale was Allergan plc, an estimated $769K.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Miscellaneous and Healthcare.
- Point View Wealth Management's largest Q2 2020 buy was Lowe's Companies: 3,692 shares worth $499K.
- Point View Wealth Management added most to Ventas in Q2 2020, an estimated $339K increase.
- Point View Wealth Management's biggest Q2 2020 reduction was BP, cutting an estimated $302K.
- Point View Wealth Management fully exited Allergan plc in Q2 2020, selling an estimated $769K.
- Point View Wealth Management's ten largest holdings make up 18% of its $208M portfolio in Q2 2020.
- Point View Wealth Management opened 17 new positions and closed 12 in Q2 2020.
- Point View Wealth Management's portfolio value rose 14% quarter-over-quarter to $208M.
Based on Point View Wealth Management's 13F filing for Q2 2020, filed 29 Jul 2020.